首页> 外国专利> TARGETING MICRORNAS MIR-409-5P, MIR-379 AND MIR-154* TO TREAT PROSTATE CANCER BONE METASTASIS AND DRUG RESISTANT LUNG CANCER

TARGETING MICRORNAS MIR-409-5P, MIR-379 AND MIR-154* TO TREAT PROSTATE CANCER BONE METASTASIS AND DRUG RESISTANT LUNG CANCER

机译:将微RNA靶向MIR-409-5P,MIR-379和MIR-154 *以治疗前列腺癌的骨转移和抗药性肺癌

摘要

The present invention describes methods of treating cancer, cancer metastasis, and drug resistant cancers using miRNA inhibitors; for example, inhibitors of miR-409-5p. Also described are methods of using the miRNA as biomarkers; for example, to predict responsiveness to a cancer drug, to detect a disease state of cancer.
机译:本发明描述了使用miRNA抑制剂治疗癌症,癌症转移和耐药性癌症的方法。例如,miR-409-5p的抑制剂。还描述了使用miRNA作为生物标记的方法。例如,预测对癌症药物的反应性,检测癌症的疾病状态。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号